Satellos Bioscience Inc. (MSLE)
Nasdaq: MSLE · Pharmaceutical Preparations · Toronto, ON · filing with the SEC since 2007
Who owns Satellos Bioscience Inc.
As filed with the SECHolders of 5% or more
2
Qiming U.S. Healthcare Fund III, L.P. holds 8.3% of Common Shares, no par value, as its SCHEDULE 13G filed May 12, 2026 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Qiming U.S. Healthcare Fund III, L.P.
SCHEDULE 13G · filed May 12, 2026 · Common Shares, no par value
Brian Matthew Bloom
SCHEDULE 13G · filed May 15, 2026 · Common Shares
What MSLE reports owning in othersstakes of 5% or more, and other ties
Satellos Bioscience Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.